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of Developmental Bisphenol A Exposure on Anxiety- and Depressive-like Behaviors in 
CD-1 Mice. Major Professor: Helen J. K. Sable, Ph.D. 
Exposure to Bisphenol A (BPA) has been linked to disruption of normal hormonal 
processes and marked behavioral changes. This study investigated the effects of perinatal 
BPA exposure on anxiety- and depression-like behaviors during adulthood in mice. 
Pregnant mice were exposed to low doses of BPA. From postnatal day 1 to 21, pups were 
directly dosed. The mice were assessed on anxiety- or depression-like behaviors using the 
Open Field, Elevated Plus Maze, Tail Suspension, and Forced Swim Tests as adults. 
Overall, the results suggest that developmental exposure to BPA may be having effects 
on anxiety-like behaviors during adulthood, while depression-like behaviors do not seem 
to be as affected. The effects on anxiety in this study are subtle; therefore, future research 
(including replication of these results) will be necessary to determine the meaningfulness 
of these results.  
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receptor modulator, mood disorders
v 
 
Table of Contents 
List of Figures          viii 
Chapter          Page 
1 Introduction         1 
  Overview of BPA       1 
  BPA’s Effects on Endogenous Estrogen and 
  Estrogen Receptors       2 
    
BPA as an endocrine disruptor (ED)    2 
    
BPA as a selective estrogen receptor    
modulator (SERM)      4 
  
  Effects of Changes in E2 Activity on Anxiety  
and Depression Behaviors      6 
Reported Effects of BPA on Behavior Including  
Measures of Anxiety and Depression     8 
Rationale and Hypotheses of Current Study    9 
2 Methods         11 
  Subjects        11 
  Exposure        11 
  Procedure        12  
   Births/weaning and reproductive/developmental  
endpoints       12 
 
   Vaginal smears      13 
   Behavioral testing      14 
    Anxiety-related behaviors    14 
    Depression-related behaviors    15 
         
vi 
 
3 Data Analysis         18 
  Behavioral Tests       18 
4 Results         19 
  Anxiety Measures       19 
   Open Field Test      19 
    Horizontal photobeam breaks    19 
    Time spent in center versus periphery  20 
    Vertical measures     22 
   Elevated Plus Maze      24 
    Entries in closed and open arms   24 
    Percent time spent in arms and 
    maze junction       24 
     
Grooming, rearing, head dipping,  
stretch-attend postures    26 
  Depression Measures       26 
   Tail Suspension Test      26 
    Duration of immobility    26 
   Forced Swim Test      27 
    Average immobility     27 
    Latency to immobility    28 
    Basic movements and swim distance   28  
5 Discussion         29 
 Summary of Results and Relation to Previous Literature  29  
  Possible Mechanisms       31 
vii 
 
  Future Research       32 
  Limitations        33 
 Conclusions        34 
References          36 
Appendices  
A.      Tables         44 
B.      Figures         47 







List of Figures 
Figure                    Page 
    1. Structures of Bisphenol A, 17 β-estradiol (E2), and ethinyl estradiol (EE2) 47 
    2. Open Field Test:  Time Spent in the Center     48 
    3. Open Field Test:  Time Spent Frozen in the Center    49  
    4. Open Field Test:  Time Spent Frozen in the Periphery    50 
    5. Open Field Test:  Vertical Counts in the Center    51 
    6. Open Field Test:  Vertical Counts in the Periphery    52 
    7. Open Field Test:  Time Spent Vertical in the Center    53 
    8. Elevated Plus Maze:  Number of Entries into Closed Arms   54 
    9. Elevated Plus Maze:  Percent Open Arm Entries    55 
    10. Elevated Plus Maze:  Percent Time Spent in Closed Arms   56 
    11. Elevated Plus Maze:  Percent Time Spent in Junction    57 
    12. Elevated Plus Maze:  Stretch-Attend Postures     58 












Chapter 1:  Introduction 
 
Overview of BPA 
Bisphenol A, otherwise known as BPA, is a ubiquitous organic compound that is 
composed of two phenol groups with attached hydroxyl substituents and is similar in 
structure to both endogenous (17 β-estradiol) and synthetic estrogen (ethinyl estradiol; 
see Figure 1). The monomeric form of the chemical reacts with itself to form polymer 
chains that are used in the production of polycarbonate plastics including food and 
beverage containers, epoxy resins in the lining of metal cans, and dental sealants 
(Palanza, Gioiosa, vom Saal, & Parmigiani, 2008). Human exposure to BPA has now 
been well established. In fact, BPA has been detected in 95% of human urine samples 
(Calafat et al., 2005). This exposure usually transpires through the ingestion of 
contaminated foods and beverages that have been in contact with epoxy resins or 
polycarbonate plastics (Lee et al., 2008). It is thought that BPA leaches out of these resins 
and plastics under conditions involving exposure to heat or to either acidic or basic 
conditions, which catalyze the hydrolysis of the ester bonds that link the BPA monomers 
(Richter et al., 2007).  
Exposure to compounds like BPA during critical periods of fetal and early 
neonatal development can bring about detrimental effects (Schonfelder, Friedrich, Paul, 
& Chahoud, 2004). These effects have been evident in numerous types of target tissues, 
from neurological to reproductive. For example, developmental BPA exposure has been 
linked to disturbance of the dopaminergic system in the brain (Suzuki, Mizuo, Sakata, & 
Narita, 2003), thyroid dysfunction (Kashiwagi et al., 2009), obesity (Rubin & Soto, 
2009), prostate (Ho, Tang, Belmonte de Frausto, & Prins, 2006) and breast (Brisken, 
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2008) cancer, morphologic defects in uterine epithelium (Schonfelder et al., 2004), and 
earlier onset of puberty (Ryan & Vandenbergh, 2006), among other abnormalities; hence, 
the significant concern for this chemical’s possible toxic consequences. 
BPA’s Effects on Endogenous Estrogen and Estrogen Receptors 
BPA as an endocrine disrupter (ED). In order to prevent these detrimental 
effects, elucidating the exact biochemical mechanism of BPA on biological tissues is 
imperative. Molecular studies using an assortment of in vitro models have proposed 
numerous molecular pathways through which BPA may evoke cellular responses. One 
specific characterization of the BPA molecule is as an ED. According to the National 
Institute of Environmental Health Sciences (NIEHS, 2010), EDs are chemicals that may 
disturb the production or activity of hormones of the endocrine system. This interference 
with natural hormonal processes may produce adverse health effects. 
BPA is a non-steroidal estrogenic compound that influences the activity of natural 
estrogen, specifically 17 β-estradiol (Wetherill et al., 2007). By mimicking endogenous 
E2, BPA obstructs normal endocrine regulation during specific developmental periods 
(Bouskine, Nebout, Brucker-Davis, & Fenichel, 2009). BPA has similar potency and 
efficacy as E2 in rapid signaling activity. For example, one study stimulated rapid-
response ERK (extracellular signal-regulated kinase) activities in the cerebellar cortex of 




 M for BPA, 10
-10
 M for E2), BPA and E2 showed 
approximately equal potency and efficacy for inducing ERK activity when administered 
alone. In addition to this mimicking action, when co-administered with E2, BPA was able 
to inhibit the quick E2-induced ERK activity in the developing cerebellum, thereby 
disrupting rapid actions of E2 at these low concentrations (Zsarnovszky, Le, Wang, & 
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Belcher, 2005).  Further evidence of BPA’s ability to act as an estrogen antagonist was 
obtained in a study that examined the effects of BPA’s co-administration with E2 in the 
hippocampus. E2 alone normally induces a rapid increase in CA1 pyramidal cell 
dendritic spine synapse density (PSSD) through activation of the mitogen-activated 
protein (MAP) kinase cascade. The data showed that BPA antagonized the rapid 
inductive effects of E2 on hippocampal PSSD. The authors suggested that the mechanism 
of BPA’s effects is likely via direct or indirect deactivation of the MAP kinase cascade 
(MacLusky, Hajszan, & Leranth, 2005).  
Molecules classified as EDs, such as BPA, can not only mimic or modify the 
endogenous action of the hormone as described above, but also can alter the expression 
of estrogen receptors, thereby interfering with normal cellular development and function 
(Palanza et al., 2008). Increases in the estrogen receptor (ER) subtypes ERα and ERβ 
have been detected in varied areas of the brain following developmental exposure to 
BPA. Specifically, male offspring of dams exposed to 25 µg/kg/day BPA from 
gestational day (GD) 8 to parturition were observed on postnatal days 30 and 120, and 
found to have permanently up-regulated ERβ mRNA levels in the preoptic area at both 
time points (Ramos et al., 2003). Neonatal injection of rat pups with a dose of 15 
mg/kg/day BPA produced increased ERα mRNA expression in the medial basal 
hypothalamus of females, and increased mRNA expression of both ERα and ERβ in the 
anterior pituitary in males (Khurana, Ranmal, & Ben-Jonathan, 2000).  
Finally, chemicals can act as EDs by altering synthesis, metabolism, and/or 
clearance. Previous experiments have demonstrated BPA’s ability to influence enzyme 
activity and metabolism in a variety of tissues. One such example is the interaction 
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between cytochrome P450 enzymes and BPA. P450 enzymes in the liver, kidney, lung, 
and intestines are vital in the metabolism of drugs and other exogenous environmental 
compounds including environmental contaminants. When foreign compounds are 
metabolized in the body, toxic metabolites may be created (Soucek & Gut, 1992). Some 
studies have proposed that the metabolism and toxicity of BPA is strongly linked to P450 
(Atkinson & Roy, 1995). It was found that BPA greatly decreased P450-dependent 
monooxygenase activities in vitro; therefore, BPA exposure may increase the amount of 
toxins and toxic metabolites in the body because the P450 enzymes that are supposed to 
transform them are inhibited (Hanioka, Jinno, Tanaka-Kagawa, Nishimura, & Ando, 
2000). 
BPA as a selective estrogen receptor modulator (SERM). Recent scientific 
data is now providing evidence that BPA is also a SERM. A SERM is a chemical that 
binds to ERs and brings about a change in biological action depending upon the type of 
tissue. SERMs have partial agonist and partial antagonist properties; their actions depend 
on the specific tissue with which they are interacting. These partial agonist or antagonist 
actions are dependent upon which transcriptional coregulators are recruited when the 
particular ligand (SERM) binds to the ER (Oseni, Patel, Pyle, & Jordan, 2008). 
Transcriptional coregulators are proteins that communicate with transcription factors to 
either activate (then called co-activators) or repress (then called co-repressors) the 
transcription of particular genes (Glass & Rosenfeld, 2000). The binding of a SERM to 
an ER produces a conformational change in the receptor that differs from E2 binding to 
the same ER. This conformational change promotes the binding of the coregulators, 
which aid in deciding the action of the SERM in that specific target site. When an 
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identical SERM ligand binds to ERα and ERβ, different conformational changes occur 
and thus different coregulators are recruited. Thus, the SERM could be an agonist at one 
ER type and an antagonist at another, all in the same tissue (Oseni et al., 2008).  
BPA has acquired this additional SERM classification, because compared to E2, 
BPA interacts differently with the ligand-binding domain of ERs, shows a distinctive 
binding affinity for and regulation of both ER types (ERα and ERβ) in target tissues, and 
displays a different way of working with transcriptional coregulators. Numerous studies 
have shown that the interactions of BPA and E2 with ERs differ, and it is probable that 
BPA induces a distinctive ER conformation when it binds (Welshons, Nagel, & vom 
Saal, 2006). The BPA-ER complex’s recruitment of some coregulators has been shown to 
be disproportionate to BPA’s binding affinity for each ER subtype. In particular, while 
BPA has a 10-fold higher binding affinity for ERβ over ERα, the BPA-ERβ complex had 
a staggering 500-fold greater potency in the recruitment for the transcriptional co-
activator TIF2 than the BPA-ERα complex, showing that not only is the ER type to 
which BPA binds important, but also that the binding to each ER can produce drastically 
different effects  (Routledge, White, Parker, & Sumpter, 2000; Wetherill et al., 2007). 
As previously mentioned, distinct SERMs are able to display a mix of agonist and 
antagonist activities within the same tissue. These varying activities may even be 
different types of agonistic behavior, with BPA acting as a full agonist at one receptor 
and a partial agonist at another.  One example of these differing actions involves BPA’s 
action in the rodent uterus. Stimulation of uterine cell proliferation and water absorption 
in the uterus of rodents is a typical assay for measuring the potency of xenobiotic 
estrogens. BPA was shown to be a weak partial agonist for stimulation of uterine wet 
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weight gain, while significantly stimulating an estrogen-responsive reporter gene in the 
same tissue (Welshons et al., 2006). 
In summary, BPA has been shown to act both as an estrogenic ED and as a 
SERM. While many chemicals act as an ED or a SERM in one specific way, the effects 
of BPA are numerous and varied which likely contributes to its toxicity. BPA alters the 
activity of endogenous E2, blocks E2 receptors and E2 receptor expression, and promotes 
conformational ER changes that affect downstream gene transcription. BPA even appears 
to prevent its own metabolism and clearance from the body further promoting its toxicity. 
It is clear that this chemical has a complicated relationship with E2 and further research 
into how they affect each other is needed. Of special significance to this study is the fact 
that BPA’s ED and SERM actions in brain tissue are still not well understood, and even 
less is known about how these actions in brain may influence the prevalence and severity 
of E2-influenced behavioral disorders, such as anxiety and depression. 
Effects of Changes in E2 Activity on Anxiety and Depression Behaviors 
E2 has numerous effects on the brain. Essentially no research has been done 
examining the effects of changes in E2 on anxiety and depression in an early 
developmental model, but it is possible to consider the effects by examining studies done 
in adult animals and post-menopausal women. Alterations in E2 levels can produce 
drastic changes in mood and affect, as alterations from normal E2 levels have been 
shown to alter anxiety and depression-like behaviors (Walf & Frye, 2010).   For example, 
in an animal study done by Walf and Frye, intact, aged (approximately 24-months old) 
female mice were examined on the Open Field Test (OFT), Elevated Plus Maze (EPM; 
both behavioral tests of anxiety), and Forced Swim Test (FST; a behavioral measure of 
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depression). Results from the OFT revealed that the mice given E2 entered significantly 
more central squares than the mice given the control vehicle. As for the EPM , the 
researchers found that the time spent in the open arms was greater in mice given E2 
compared to the control group. Both of these behaviors are indicative of less anxiety. 
Results from the FST demonstrated that mice given E2 exhibited a shorter duration of 
immobility compared to control animals. Immobility is a sign of learned helplessness 
which is associated with depression. Thus, E2 administration appeared to result in less 
anxiety (i.e., E2 was anxiolytic) as well as decreased depressive-like behaviors.  
In humans, there is little research examining the influence of menopausal state on 
anxiety and whether or not E2 interacts with menopausal state to alter anxiety. In one of 
the rare studies that investigated this question, researchers found that E2-treated post-
menopausal women actually showed an increase in negative mood and anxiety after they 
were given the Trier Social Stress Test (TSST), as compared to placebo-treated women 
(Newhouse et al., 2007).  Regarding depression, post-menopausal women have 
significantly higher depression scores on the Edinburgh Depression Scale than pre- and 
peri-menopausal women (Maartens, Knottnerus, & Pop, 2002). Thus, it appears that the 
very low level of E2 found in post-menopausal women is associated with higher anxiety 
and depression scores. Interestingly, Sherwin (1994) reported that E2 improved 
depression symptoms in post-menopausal women in a dose-dependent manner.     
As previously mentioned, there is little reported research about how changes in 
E2 during early development affect anxiety and depression. During fetal life, E2 is a 
major factor in the organization of neural circuitry that manages many different 
neuroendocrine, cognitive, and behavioral functions. Therefore, changes in E2, which 
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would occur via the introduction of EDs and SERMS such as BPA during early 
development, would likely produce long-term disruption of E2.  This interference may 
then alter anxiety- and depression-like behavior in a manner similar to what is observed 
when E2 is altered during adulthood. As presented below, there is some limited evidence 
(to date) that this is the case. 
Reported Effects of BPA on Behavior Including Measures of Anxiety and 
Depression 
Other published studies have reported that BPA exerts significant effects on the 
brain both structurally and neurochemically, and these outcomes have been linked to 
behavioral changes such as hyperactivity, learning deficits, amplified aggression, and 
increased tendencies for drug addiction (Welshons et al., 2006). Relevant to the current 
study, Palanza et al. (2008) looked at explorative and emotional behaviors, specifically 
risk assessment and anxiety behaviors, in mice perinatally exposed to BPA (10 
µg/kg/day). They found that the sex differences usually present in control animals were 
decreased or eliminated in mice exposed to BPA. In particular, BPA-exposed females 
displayed levels of exploratory behavior more like the usual behaviors detected in control 
males. In general, they found that there was a decrease or reversal of sex differences in 
the mice exposed to BPA, compared to the control mice.  
Likewise, Ryan and Vandenbergh (2006) also investigated the effects of exposure 
to BPA on sexually dimorphic anxiety behaviors in mice. For this study, mice were 
exposed to either 2 or 200 µg/kg/day of BPA or 5 µg/kg/day of ethinyl estradiol (EE2) 
during perinatal development. Behavioral testing began on PND 42, when all subjects 
had reached early adulthood. Using the EPM, the researchers found that the group 
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exposed to EE2 spent significantly less time in the open arms compared to mice in the 
control group. The group that had been exposed to the higher dose of BPA also spent less 
time in the open arms of the maze, indicative of anxiogenic behavior.  
There is substantial co-morbidity among anxiety disorders and depression 
(Hirschfeld, 2001), yet little research has been done on how alterations in E2 activity by 
EDs or SERMs affect depression-like behaviors. Extensive literature searches regarding 
this subject generated only one relevant study investigating depression-like behaviors 
following BPA exposure in rats. Perinatal BPA exposure (0 or 15 µg/kg/day BPA) 
significantly increased immobility time in the FST, with immobility representing a type 
of depression-like behavior called learned helplessness or behavioral despair (Fujimoto, 
Kubo, & Aou, 2006).  
Rationale and Hypotheses of the Current Study 
Upon examination of the literature regarding the observed effects of BPA on the 
brain and neuroendocrine system, there are numerous reports that BPA is producing 
pharmacological effects on E2, and some is known about the how alterations in E2 affect 
behavioral measures of anxiety and depression. In addition, limited studies have 
determined that BPA exposure can alter anxiety- and depression-like behavior in rodents, 
but these studies have been conducted in different labs often with limited BPA doses, in 
different species (rats vs. mice), using only a single measure of each construct on only a 
single sex, and without a positive control for BPA. The current project used a mouse 
model to assess the effects of developmental exposure to multiple low doses of BPA 
(relative to a zero dose and positive control) in both male and female offspring on two 
different measures of anxiety and two different measures of depression – all of which 
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have been well-validated. It was with careful consideration of the previously discussed 
research that resulted in an overall hypothesis that low dose BPA exposure would result 
in an overall increase in anxiety- and depression-like behaviors relative to non-exposed 
control animals. Given that some of the behavioral tests included had been previously 
reported to produce sexually dimorphic behavior in mice (OFT = Beatty, 1979; EPM = 
Gioiosa, Fissore, Ghirardelli, Parmigiani, & Palanza, 2007; FST = Pelloux, Hagues, 
Contentin, & Duterte-Boucher, 2005), it was also expected that the relative degree to 
which these behaviors would be affected by BPA exposure might differ between the 




Chapter 2:  Methods 
Subjects 
Female CD-1 mice that were timed pregnant were obtained from Charles River 
Laboratories.  This particular strain of mouse was chosen to be consistent with other 
research (Gioiosa et al., 2007; Palanza et al., 2008; Tian, Baek, Lee, & Jang, 2010). Each 
female was single-housed in a standard non-polycarbonate plastic shoebox cage 
(inspected and determined to be free of wear) with wood chip bedding.  A standard soy 
free rat diet (2020X; Harlan-Teklad, Madison, WI) and reverse-osmosis filtered water in 
glass bottles was available ad libitum.  The mice were maintained in a temperature- and 
humidity-controlled room (22 °C, 40-55% humidity) on a 12:12 hour regular light-dark 
cycle (on at 0700, off at 1,900 hours).  All procedures were approved by the Institutional 
Animal Care and Use Committee (IACUC) at the University of Memphis and were in 
accordance with the Public Health Service Policy on Humane Care and Use of 
Laboratory Animals (National Institutes of Health [NIH], 2002) and the Guidelines for 
the Care and Use of Mammals in Neuroscience and Behavioral Research (National 
Research Council [NRC], 2003).   
Exposure 
On GD 11, the female mice were assigned to exposure groups (balanced for body 
weight) and given one of five treatments consisting of either BPA (2, 20, or 200 
μg/kg/day; Sigma Aldrich, St. Louis) or ethinyl estradiol (5 μg/kg/day; positive control; 
Sigma) dissolved in tocopherol-stripped corn oil (Sigma), or the control vehicle 
(tocopherol-stripped corn oil only).  These doses were selected to include two lower and 
one higher dose than the currently approved US Environmental Protection Agency (US 
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EPA) reference dose of 50 μg/kg/day (US Environmental Protection Agency [US EPA], 
2010). In addition, all doses were less than 5 mg/kg/day, which the National Toxicology 
Program uses as the upper limit to define “low” doses (Melnick et al., 2002). Each dose 
was pipetted onto one-fourth of a vanilla wafer cookie (Keebler Golden Vanilla 
Wafers®) at a volume of 0.4 mL/kg.  The pregnant mice were fed the adulterated cookie 
daily beginning on GD 11 and continuing until their offspring were born on PND 0. Due 
to the fact that BPA does not readily make its way into breast milk (Doerge, 
Vanlandingham, Twaddle, & Delclos, 2010), beginning on PND 1 and continuing until 
pups were weaned on PND 21, the pups received the same dose as their respective dam, 
by using a pipette to directly administer the appropriate oral dose.   
This dosing duration was based on mammalian brain development.  In mice and 
rats, a critical time of central nervous system (CNS) development is from late prenatal 
life until the first 2 weeks after birth.  During this time, E2 is a major factor in the 
organization of neural circuitry that manage many different neuroendocrine, cognitive, 
and behavioral functions (Palanza et al., 2008). This dosing timeline was also chosen to 
be consistent with other BPA behavioral studies (Gioiosa et al., 2007; Palanza et al. 
2008).  
Procedure 
Births/weaning and reproductive/developmental endpoints. On the day of 
parturition (PND 0), all the pups were sexed, weighed, and examined for any 
abnormalities.  Any incidence of stillbirth was also recorded.  On PND 2, the litters were 
adjusted to 10 pups (5 males and 5 females when possible).  In order to increase the size 
of small litters and to guarantee that each litter contains at least 8 to 10 pups; extra pups 
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from the same treatment group and of the same age were cross-fostered if available.  
Cross-fostered pups were marked by ear clip and did not undergo behavioral testing. 
Postnatal weight gain was monitored by weighing the pups daily until weaning on PND 
21. 
On the day of weaning, each litter’s dam was euthanized and her uterine 
implantation sites noted.  From each litter, 2 males and 2 females received ear punch 
identification and were retained for behavioral testing. They were housed in same-sex, 
same-exposure groups consisting of 2 mice per cage.  The remaining pups in each litter 
were euthanized at weaning with trunk blood and weights of the brain acquired from 1 
male and 1 female per litter (when available).  
Vaginal smears. Beginning on PND 55, the estrus stage of the adult female 
offspring was tracked by taking daily vaginal smears. Tracking continued until the mice 
completed both behavioral tests and lasted approximately 45 days. The stage of the cycle 
was determined by examining the cellular profile of each sample as described by 
Hubscher, Brooks, and Johnson (2005). As the stage of the estrus cycle is associated with 
differences in levels of endogenous E2, behavioral testing was scheduled to occur when 
each mouse was in diestrus (when E2 is the lowest). Vaginal smears were also taken after 
each behavioral test to confirm the estrus stage. In some cases, females did not regularly 
exhibit diestrus, so testing occurred during a 2nd continuous day in metaestrus when E2 
levels are more likely to be declining rather than surging (Caligioni, 2009; Walmer, 






Anxiety-related behaviors. Two behavioral tests designed to examine anxiety-
related behaviors in mice were conducted on one pair of male and female littermates. The 
first anxiety behavioral test was the Open Field Test (OFT), which has been used 
extensively in the literature as a behavioral measure of anxiety (Choleris, Thomas, 
Kavaliers, & Prato, 2001). In the OFT, anxiety is quantified based on how much time the 
animal spends in the center versus the periphery of the testing chamber. Time spent near 
the periphery is indicative of an anxiogenic state (increased anxiety) while time in the 
center of the arena suggests an anxiolytic state (decreased anxiety). The OFT occurred 
around PND 75 (and during diestrus/day 2 of metaestrus for the females). Testing 
occurred during the middle of the light cycle, generally between 1,400 or 1,500 hours. 
The OFT chamber (Med Associates; St. Albans, VT) consisted of a square plastic arena 
(46.5 x 46.5 x 46.5 cm) bisected with photobeams and equipped with a tracking system. 
Each mouse was placed in the center of the arena and allowed to move freely for 10 
minutes.  Dependent measures included (a) the number of photobeam breaks in the center 
area, (b) number of photobeam breaks in the periphery, (c) duration of time spent in the 
center area, (d) duration of time spent frozen in the center area, (e) duration of time spent 
frozen in the periphery, (f) number of vertical photobeam breaks in the center area, (g) 
number of vertical photobeam breaks in the periphery, (h) duration of time spent vertical 
in the center area, and (i) duration of time spent vertical in the periphery. 
The next anxiety test for each subject was the Elevated Plus Maze (EPM) which is 
one of the most commonly used behavioral measures of anxiety (Rodgers & Dalvi, 
1997). Anxiogenic behavior is associated with time spent in the closed arms, while 
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anxiolytic behavior is associated with time spent in the open arms. Testing on the EPM 
occurred on approximately PND 85 (and during diestrus/day 2 of metaestrus for the 
females) and lasted for 5 minutes.  The EPM apparatus consisted of two open (6 x 76 x 
21 cm) and two closed arms all equipped with photobeams to record animal entries, and 
an open roof.  The maze was constructed of black Plexiglas, illuminated with dim red 
light, and placed at an elevation of approximately 74 cm from the floor.  Each mouse was 
placed in the center of the maze facing an open arm (see Rodgers et al., 1999).  
Photobeams recorded entries into each arm and sessions were also video-recorded for 
subsequent analysis. A thorough cleaning of the maze occurred between each subject. 
The dependent measures collected were similar to those reported by Rodgers et al. (1999) 
and included (a) number of total closed arm entries (all four paws into arm), (b) number 
of total open arm entries (all four paws into arm), (c) percent open entries, (d) percent 
time spent in closed arms, (e) percent time spent in open arms, (f) percent time spent in 
junction of the maze, (g) duration spent  grooming, (h) frequency of rearing, (i) frequency 
of head dipping (head/shoulders over the side of the maze), and (j) frequency of stretch-
attend postures (body is stretched forward then retracted back without forward 
locomotion).  
Depression-related behaviors. Two measures of depression-like behavior were 
conducted on the other male and female from each litter. The Tail Suspension Test (TST) 
has been extensively used to measure depression-behavior in mice (Cryan, Mombereau, 
& Vassout, 2005). For this test, immobility while suspended is likened to hopelessness 
and giving up which are significant characteristics of depression (Cryan et al., 2005). The 
TST was conducted on approximately PND 80 and occurred when the female mice were 
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in diestrus/day 2 of metaestrus.  The TST apparatus (Kinder Scientific; San Diego, CA) 
consisted of a cubicle furnished with a strain gauge which is a hook linked to a vertical 
bar that digitally detected mobility.  The mouse was suspended by its tail with tape from 
the strain gauge for 6 minutes.  The total duration of immobility was the dependent 
measure and was computed as the total time the subject’s movement was below a pre-
determined threshold (< 0.20 Newtons for > 40 msec).  Specifically, immobility was 
characterized as the lack of any initiated movements and included passive swaying. In a 
few instances, the mouse climbed its tail during testing in order to grab the hook. In such 
cases, testing was terminated and the mouse re-tested on one additional occasion on a 
different day. If a mouse climbed its tail on two separate occasions, it was not re-tested. 
  The second depression measure was the Forced Swim Test (FST). Each subject 
underwent this measurement on approximately PND 90 (during diestrus/day 2 of 
metaestrus in the females).  The FST apparatus (Kinder Scientific; San Diego, CA) 
consisted of a clear glass cylinder (height = 24 cm; diameter = 13 cm) filled with fresh 
tap water up to the level of 14 cm. The FST protocol used has been previously described 
(Castagne, Porsolt, & Moser, 2009). Each mouse was placed in the water-filled cylinder 
(temperature ~ 22 °C) for 6 minutes.  Early removal (i.e., rescue) would have occurred if 
the mouse made at least two successive descents (not dives) to the bottom of the testing 
chamber, with no attempt to swim or effort made to the reach water’s surface.  However, 
rescue was never necessary and did not occur. Afterwards, the subject was removed, 
towel dried, placed in a recovery cage which was placed on a heating pad for about 15 
minutes, and returned to its home cage.  The testing apparatus was emptied, rinsed, and 
refilled with fresh water after each subject’s test session to eliminate any pheromone 
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effects. The duration of two behaviors were measured:  (a) immobility or floating 
(making only those movements absolutely necessary to keep the head above water), and 
(b) latency to immobility. In addition, (c) basic movements (making lively movements 




Chapter 3:  Data Analysis 
Behavioral Tests 
The data analysis for each anxiety- and depression-related behavior was 
essentially the same. Each dependent variable was analyzed with a 5 (Exposure Group) x 
2 (Sex) mixed ANOVA where sex (nested within litter) was a repeated-measures factor. 
In addition, some variables also included minute as a repeated measures factor in order to 
examine changes in the dependent variable across time (see Table 1).  All statistical 
analyses were conducted using SPSS for MS Windows (version 15.0, SPSS Inc.; 
Chicago, IL) with statistical significance set at p < 0.05. When significant exposure-
related effects were obtained from the overall analyses, additional Dunnett post hoc 
analyses were conducted to determine which exposure groups differed from the control. 
If the Exposure x Sex interaction was significant, Dunnett tests were conducted 
separately for each sex. In addition, post hoc paired-samples t-tests (employing a 
Bonferroni adjusted alpha level of 0.01 (= 0.05/5) were also conducted for each exposure 




Chapter 4:  Results 
 In the case of any extreme outliers, (defined as a data point that more than 2 
standard deviations above or below its respective mean), mean substitution was 
employed. To ensure that this did not dramatically alter the experimental results, any 
dependent variable that required mean substitution was analyzed both with the substituted 
mean and also by dropping the entire litter (both male and female) from the analysis. 
Anxiety Measures 
Open Field Test. 
Horizontal photobeam breaks. For photobeam breaks in the center of the testing 
chamber, 1 male from the control group, 1 male from the EE2 group, 1 male from the 2 
BPA group, and 3 males from the 200 BPA group had data points that were determined 
to be extreme scores. Substituting the mean for these values did not change the pattern of 
results. The omnibus analysis revealed that there was a nearly significant main effect of 
sex [F(1,37) = 3.103, p = .086] where on average, males (M = 64.40, SEM = 4.048) made 
more photobeam breaks in the center of the chamber than females (M = 57.042, SEM = 
3.173). There was also a significant main effect of minute [F(9,29) = 21.388, p < .001]. 
Overall, the animals made fewer photobeam breaks in the center of the chamber as the 
test progressed. There was not a significant main effect of exposure or significant 
Exposure x Sex, Exposure x Minute, or Exposure x Sex x Minute interactions. 
For photobeam breaks in the periphery of the chamber, 1 male from the EE2 
group had a data point that was determined to be an extreme score. Substituting the mean 
for this value did not change the overall pattern of results. The omnibus analysis revealed 
that there was a significant main effect of sex [F(1,37) = 4.361, p = .044] where on 
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average, males (M = 58.061, SEM = 2.650) made more photobeam breaks in the 
periphery of the chamber than females (M = 51.171, SEM = 2.444). There was also a 
significant main effect of minute [F(9,29) = 22.745, p < .001]. Overall, the animals made 
fewer photobeam breaks in the periphery of the chamber as the test progressed. There 
was not a significant main effect of exposure or significant Exposure x Sex, Exposure x 
Minute, or Exposure x Sex x Minute interactions. 
Time spent in center versus periphery. For time spent in the center versus the 
periphery, 1 female from the control group, 1 male and 2 females from the 2 BPA group, 
and 2 males from the 20 BPA group had data points that were determined to be extreme 
scores. Substituting the mean for these values did not change the overall pattern of 
results. The omnibus analysis revealed that there was a nearly significant main effect of 
exposure [ F(4,37) = 2.498, p = .059] and a significant main effect of minute [F(9,29) = 
4.249, p = .001]. The Exposure x Sex interaction also approached significance [F(4,37) = 
2.226, p = .085]. However, there was not a significant main effect of sex or significant 
Exposure x Minute or Exposure x Sex x Minute interactions. Post hoc Dunnett tests 
conducted separately for the males and females revealed no significant difference 
between animals in the control group from those in any of the exposure groups. Further 
analysis of sex differences within each exposure group revealed no significant sex 
differences in any of the exposure groups (see Figure 2). 
For time spent frozen in the center, 1 male and 2 females from the control group, 
2 males from the EE2 group, 2 males and 2 females from the 2 BPA group, 2 males from 
the 20 BPA group, and 1 female from the 200 BPA group had data points that were 
determined to be extreme scores. Substituting the mean for these values did not change 
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the pattern of results. The omnibus analysis revealed a trend toward a significant main 
effect of exposure [F(4,37) = 2.358, p = .071], a significant main effect of minute 
[F(9,29) = 3.377, p = .006], and a significant Exposure x Sex interaction [F(4,37) = 
2.689, p = .046]. However, there was not a significant main effect of sex or significant 
Exposure x Minute or Exposure x Sex x Minute interaction. Post hoc Dunnett tests 
conducted separately for the males and females revealed only that females in the 20 BPA 
group spent more time frozen in the center of the chamber than females in the control 
group (p = .043). Further analysis of sex differences within each exposure group revealed 
no significant sex differences in any of the exposure groups (see Figure 3). 
For time spent frozen in the periphery, 2 males and 3 females from the EE2 
group, 1 male and 1 female from the 20 BPA group, and 2 females from the 200 BPA 
group had data points that were determined to be extreme scores. Substituting the means 
for these values did not change the overall pattern of results. The omnibus analysis 
revealed a significant main effect of exposure [F(4,37) = 3.519, p = .016] as well as a 
significant main effect of minute [F(9,29) = 51.176, p < .001]. There was also a 
significant Exposure x Sex interaction [F(4,37) = 2.673, p = .047] and a nearly significant 
Exposure x Minute interaction [F(36, 128) = 1.442, p = .072]. Additional Dunnett tests 
conducted separately for the males and females revealed only that males in the EE2 group 
spent more time frozen in the periphery than males from the control group (p = .015). 
Further analysis of sex differences within each exposure group revealed no significant 
sex differences in any of the exposure groups (see Figure 4).  
Minute by minute analysis revealed a significant difference of exposure within the 
4th [F(4,37) = 4.460, p = .005], 5th [F(4,37) = 3.702, p = .012], and 6th [F(4,37) = 3.663, 
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p = .013] minutes. A trend toward a significant exposure difference was found in the 7th 
minute [F(4,37) = 2.287, p = .078]. In the 4th, 5th, and 6th minutes, animals in the EE2 
group spent more time frozen in the periphery than control animals (p = .026, p = .048, 
and p = .024, respectively). Also, in the 6th minute, animals in the 2 BPA group (p = 
.006), and the 200 BPA group (p = .016) spent more time frozen in the periphery than 
those in the control group. Dunnett post hoc analysis revealed no significant difference 
between control animals and those in the other exposure groups during the 7th minute. 
Vertical measures. No extreme scores were found for vertical counts in the center 
of the chamber. The omnibus analysis revealed that there was a significant overall main 
effect of exposure [F(4,37) = 2.853, p = .037], sex [F(1,37) = 9.837, p = .003], and a 
nearly significant Exposure x Sex interaction [F(4,37) = 2.482, p = .060]. Separate 
Dunnett post hoc analyses for the males and females only revealed a trend toward a 
significant difference between males in the 0 BPA group from males the EE2 group, with 
those in the control group making more vertical movements in the center of the chamber 
than those in the positive control group (p = .064). Further analysis of sex differences 
within each exposure group revealed a significant difference between males and females 
in the 200 BPA group, p = .001 (see Figure 5).  
 Two males, 1 in the EE2 group and 1 in the 20 BPA group, had data points that 
were determined to be extreme scores for vertical counts in the periphery. Substituting 
the mean for these values did not change the overall pattern of results. The omnibus 
analysis revealed there was a significant main effect of sex [F(1,37) = 14.146, p = .001] 
and a nearly significant Exposure x Sex interaction [F(4,37) = 2.588, p = .053], but not a 
significant main effect of exposure alone. Separate post hoc Dunnett tests for each sex 
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revealed no significant differences from controls. Further analysis of sex differences 
within each exposure group revealed a significant difference between males and females 
in the EE2 group (p = .001; see Figure 6). 
 For time spent vertical in the center of the chamber, 1 female in the 2 BPA group 
had a data point that was determined to be an extreme score for this variable. Substituting 
the mean for this value did not change the overall pattern of results. The omnibus analysis 
revealed there was a significant overall main effect of exposure [F(4,37) = 2.939, p = 
.033] and sex [F(1,37) = 17.479, p < .001]. No significant Exposure x Sex interaction was 
found. Males spent more time (in seconds) vertical in the center of the chamber than 
females (Males: M = 21.31, SEM = 2.25; Females: M = 10.98, SEM = 1.57). Post hoc 
Dunnett tests revealed a trend toward significance where mice in the 0 BPA group spent 
more time in a vertical position than mice in the EE2 positive control group (p = .078). In 
addition, mice in the 0 BPA group spent significantly more time in a vertical position 
than mice in both the 2 BPA group (p = .024), and the 200 BPA group (p = .045; see 
Figure 7).  
 For time spent vertical in the periphery of the chamber, 1 male in the EE2 group 
had a data point that was determined to be an extreme score for this variable. Substituting 
the mean for this value did not change the overall pattern of results. The omnibus analysis 
revealed there was a significant main effect of sex [F(1,37) = 69.563, p < .001] with 
males (M = 156.72, SEM = 3.99) spending more time (in seconds) vertical in the 
periphery of the chamber than females (M = 106.09, SEM = 3.73). Neither the main effect 




Elevated Plus Maze. 
Entries in closed and open arms.  No extreme scores were found in the number 
of closed arm entries. The omnibus analysis revealed that there was not a significant main 
effect of sex or a significant Exposure x Sex interaction. There was a significant main 
effect of exposure [F(4,37) = 3.468, p = .017]; however, post hoc Dunnett tests revealed 
no significant differences (see Figure 8).  
For the number of open arm entries, data from 1 female in the 200 BPA group 
was determined to be an extreme score for this variable. Substituting the mean for this 
value did not change the overall pattern of results. The omnibus analysis revealed that 
there was not a significant main effect of sex or exposure or a significant Exposure x Sex 
interaction. 
The percent of entries into the open arms was also examined and no extreme 
scores were found in these data. The percentage of open arm entries was calculated 
according to the following formula:  Number of entries into open arms/(Number of 
entries into open arms + Number of entries into closed arms) x 100. The omnibus 
analysis revealed that there was not a significant main effect of sex or significant 
Exposure x Sex interaction. There was a trend toward significance for the exposure main 
effect [F(4,37) = 2.252, p = .082], but post hoc Dunnett tests revealed no significant 
differences (see Figure 9). 
Percent time spent in arms and maze junction. The percentage of time spent in 
the closed arms was calculated according to the following formula:  Time spent in closed 
arms/ (Time spent in closed arms + Time spent in open arms + Time spent in junction) x 
100. One male from the EE2 group had a data point that was determined to be an extreme 
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score for the percent time spent in the closed arms. Substituting the mean for this value 
did not change the overall pattern of results. The omnibus analysis revealed that there 
was not a significant main effect of sex or significant Exposure x Sex interaction. There 
was a near significant main effect of exposure [F(4,37) = 2.551, p = .055] but post hoc 
Dunnett tests revealed no significant differences from the control group (see Figure 10).  
The percentage of time spent in the open arms was calculated according to the 
following formula:  Time spent in open arms/ (Time spent in closed arms + Time spent in 
open arms + Time spent in junction) x 100. For the percent time spent in the open arms, 
data from 2 males, both in the EE2 group, were determined to be extreme scores for this 
variable. Substituting the mean for these values did not change the overall pattern of 
results. The omnibus analysis revealed that there was not a significant main effect of 
exposure or significant Exposure x Sex interaction but there was a significant main effect 
of sex [F(1,37) = 6.822, p = .013]. Females (M = 29.73, SEM = 1.64) spent a larger 
percentage of time in the open arms compared to males (M = 24.69, SEM = 1.42).  
The percentage of time spent in the junction was calculated according to the 
following formula:  Time spent in junction/ (Time spent in closed arms + Time spent in 
open arms + Time spent in junction) x 100. No extreme scores were found in the percent 
time spent in the junction of the maze. The omnibus analysis revealed that there was a 
nearly significant main effect of exposure [F(4,37) = 2.564, p = .054] and a significant 
main effect of sex [F(1,37) = 7.863, p = .008]. The Exposure x Sex interaction was not 
significant. Post hoc Dunnett tests (collapsed across sex) revealed that mice in the 0 
µg/kg BPA group spent significantly less time in the junction of the maze than mice in 
the 20 µg/kg BPA dosing group (p = .033; see Figure 11). Overall, males (M = 51.52, 
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SEM = 1.34) spent a larger percentage of time in the junction of the maze than females 
(M = 45.61, SEM = 1.51).   
Grooming, rearing, head dipping, stretch-attend postures. One male from the 20 
BPA group had a missing data for all of these measures due to a video camera 
malfunction. For the duration spent grooming, 1 additional male from the EE2 group and 
2 BPA group as well as 1 female from the 20 BPA group had data points that were 
determined to be extreme scores for this variable. Substituting the mean for these values 
did not change the overall pattern of results. No additional outliers were found for 
frequency of rearing, head dipping, or stretch-attend postures. The omnibus analyses for 
duration spent grooming, frequency of rearing, and frequency of head dipping revealed 
that there was not a significant main effect of exposure or sex or a significant Exposure x 
Sex interaction for any of these variables. The omnibus analysis for frequency of stretch-
attend postures revealed there was not a significant main effect of sex or exposure. 
However, there was a trend toward a significant Exposure x Sex interaction [F(4,37) = 
2.335, p = .073]. Separate post hoc Dunnett tests for each sex revealed no significant 
differences from controls. Further analysis of sex differences revealed no significant 
differences between males and females in any of the exposure groups (see Figure 12). 
Depression Measures 
Tail Suspension Test. 
Duration of immobility. One male from the EE2 group, 1 female from the 2 BPA 
group, 1 male from the 20 BPA group, and 2 females from the 200 BPA group climbed 
up their tail on two separate occasions and therefore failed to complete this behavioral 
test. In addition, 2 males from the control group, 1 male and 2 females from the EE2 
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group, 1 male and 1 female from the 2 BPA group, 2 males from the 20 BPA group, and 
1 male and 2 females from the 200 BPA group had data points that were determined to be 
extreme outliers for this variable. Substituting the mean for these values did not change 
the overall pattern of results. The omnibus analysis revealed that there was a significant 
main effect of minute [F(5,33) = 13.50, p < .001] and a significant Exposure x Minute 
interaction [F(20,144) = 1.750, p = .032]. There was no significant main effect of 
exposure or sex, as well as no significant Exposure x Sex or Exposure x Sex x Minute 
interaction. A significant effect of exposure was found in the 1st [F(4,37) = 4.583, p = 
.004] and 5th [F(4,37) = 3.318, p = .020] minutes, but Dunnett post hoc analysis at each 
minute revealed no significant difference between control animals and those in the other 
exposure groups.  
Forced Swim Test. 
Average immobility. One male from the EE2 group died before testing began due 
to illness. There was also an outlier for a female in the EE2 group for the 1st minute of 
testing. Substituting the mean for each of these dependent values did not change the 
overall pattern of results. The omnibus analysis of average immobility revealed that there 
was a significant main effect of sex [F(1,37) = 29.992, p < .001] and a significant main 
effect of minute [F(5,33) = 405.43, p < .001]. There were also significant Exposure x 
Minute [F(20,144) = 1.66, p = .046], and Sex x Minute, [F(5,33) = 7.59, p < .001] 
interactions. There was no significant main effect of exposure, or significant Exposure x 
Sex or Exposure x Sex x Minute interactions found. Additional post hoc analysis revealed 
a difference of exposure only within the 1st minute [F(4, 37) = 4.700, p=.004] with 
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control animals being significantly more immobile than animals in the 20 BPA (p=.022), 
200 BPA (p=.006), and the EE2 (p=.004) groups (see Figure 13). 
Latency to immobility. For the latency to immobility variable, in addition to the 
missing data point from the male in the EE2 group, 1 female from the 20 µg/kg BPA 
dosing group had a data point that was determined to be an extreme outlier. Substituting 
the mean for these values did not change the overall pattern of results. The omnibus 
analysis revealed that there was not a significant main effect of sex or exposure or a 
significant Exposure x Sex interaction. 
Basic movements and swim distance. The omnibus analysis of basic movements 
revealed that there was a trend toward significance for the main effect of sex, F(1,37) = 
3.565, p = .067, with males (M = 488.33, SEM = 12.40) making more basic movements 
than females (M = 462.52, SEM = 12.52).  However, there was no significant main effect 
of exposure or significant Exposure x Sex interaction. For swim distance, the omnibus 
analysis revealed that there was a significant main effect of sex, F(1,37) = 11.907, p = 
.001, with males (M = 458.59, SEM = 12.43) swimming a longer distance (in centimeters) 
than females (M = 407.36, SEM = 12.15). However, there was no significant main effect 




Chapter 5:  Discussion 
Summary of Results and Relation to Previous Literature 
The overall results of this study illustrated that anxiety-like behavior in CD-1 
mice developmentally exposed to BPA was slightly affected although the results were not 
overwhelmingly conclusive (see Table 2). In particular, mice belonging to BPA exposure 
groups exhibited various behaviors indicating a higher state of anxiety relative to the 
control mice. Mice developmentally exposed to BPA spent more time frozen in both the 
center and periphery of the OFT chamber than control mice. In addition, the BPA mice 
generally spent less time in a vertical position in the OFT than the control mice, 
indicative of a decrease in exploratory behavior which is associated with increased 
anxiety (Palanza et al., 2008). A similar reduction in exploratory behavior was suggested 
in the EPM, where mice in the 20 µg/kg/day BPA group spent more time in the junction 
(rather than exploring the arms) relative to control mice.  
The current results are not inconsistent with other studies which show BPA’s 
possible influence on anxiety-like behaviors following developmental exposure. 
Nakamura et al. (2011) found that CD-1 mice developmentally exposed to BPA showed a 
lower total distance traveled in the Open Field Test. Likewise, in the Elevated Plus Maze, 
they again observed that the BPA-exposed group did not explore as much as the non-
exposed controls. Ryan and Vandenbergh (2006) also observed mice developmentally 
exposed to 200 µg/kg/day BPA via oral gavaging of the dam from GD 3 to PND 21 spent 
less time in the open arms of the EPM than non-exposed control animals. Patisaul and 
Bateman (2008) found that male rats neonatally exposed via subcutaneous injections to 
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BPA for 4 days made significantly fewer open arm entries and spent significantly less 
time in the open arms in the EPM compared to control animals. 
One very important consideration in all of these studies relates to the doses of 
BPA used and route of administration. It is important to note that Nakamura et al. (2011) 
began dosing dams on GD 0 instead of GD 11, and used only a 20 µg/kg/day dose of 
BPA which was given via subcutaneous injection to the dam; they did not implement 
direct oral dosing for the pups. Patisaul and Bateman (2008) also utilized subcutaneous 
injections as the route of administration to neonatal male rat pups from PND 0 to PND 3 
only. It has been shown that subcutaneous administration of BPA causes much higher 
circulating BPA levels than oral exposure (Doerge, Twaddle, Vanlandingham, & Fisher, 
2010). Thus, one possibility is that subcutaneous delivery of BPA may be better able to 
alter anxiety-like behavior on the OFT and EPM. However, this does not seem likely as 
Ryan and Vandenbergh (2006) used oral exposure during early gestation and lactation 
and found an increase in certain anxiety measures in BPA exposed mice.    
Tian et al. (2010) also saw effects on anxiety-like behaviors in CD-1 mice 
following developmental exposure to BPA.  Similar to this study’s results, BPA exposed 
animals did not differ from controls in how many entries into open arms they made. 
However, they observed that mice developmentally exposed to 500 µg/kg/day BPA 
actually spent significantly more time in the open arms on the Elevated Plus Maze, an 
indication of a decreased anxiety-like state. Tian et al. began oral administration of 
vehicle, 100, or 500 µg/kg/day BPA to the dams from GD 7 to PND 21 and their 
offspring were then assigned to either BPA or vehicle according to maternal treatment 
from PND 22 TO 36. In addition, behavioral testing occurred when the mice were 5-
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weeks old. Thus differences in the duration of exposure and age at which the mice were 
tested may also explain the differing anxiety outcomes between Tian et al. in comparison 
to the current study as well as those of Nakamura et al. (2011), Ryan and Vandenbergh 
(2006), and  Patisaul and Bateman (2008).  
 Unlike for the anxiety measures, there was little evidence to suggest 
developmental exposure to BPA caused any type of change in depression-like behaviors 
(see Table 3). The only exposure related difference found in the depression measures was 
a slight decrease in immobility in the 20 and 200 BPA mice compared to controls during 
the first minute of the Forced Swim Test. This was only a 4- to 5-second difference (in 
the scope of a 6-minute test). A difference this small does not seem very meaningful. 
Thus, the results suggest that depression may not be profoundly affected following 
developmental exposure to BPA-containing products. 
Possible Mechanisms 
 The BPA-induced behavioral changes have a likely neuropharmacological cause 
due to developmental BPA exposure. As explained in the introduction, BPA has been 
shown to have numerous cellular and neurological effects in the brain by acting as an 
EED and a SERM. Future research will need to determine whether estrogenic endocrine 
disruption or modulation of estrogen receptors resulting from BPA exposure is 
responsible for the later changes in anxiety that have been reported.  
Recent research has also begun to examine the effect of BPA exposure on brain 
dopamine (DA) function. Using single-photon emission computerized tomography, 
Schneier et al. (2008) reported that the generalized type of social anxiety disorder 
(GSAD) was a result of abnormal central dopamine function and demonstrated that 
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unmedicated adults who had been diagnosed with GSAD had a low availability of D2 
receptors in the striatum. Tian et al. (2010) investigated whether BPA had the ability to 
change the dopaminergic system by utilizing radioligand binding for D1 and D2 receptors 
and the dopamine transporter (DAT). They found that D2 receptor binding increased but 
DAT binding decreased in the striatum. D1 receptor binding was not altered in the BPA-
treated mice. Thus, these results indicate that changes in the expression of D2 receptors 
and DAT in the striatum may be associated with alterations in anxiety-like behaviors in 
BPA-exposed mice. Research examining the influence of BPA on DA receptor 
mechanisms is quite novel. Clearly, future research will need to examine how BPA 
exposure is associated with dopamine dysfunction including how BPA-induced changes 
in receptor function that occur during early development may lead to long-term 
behavioral changes.  
Future Research 
In the real world, BPA exposure is life-long. Ninety-five percent of adult humans 
show detectable levels of BPA (Calafat et al., 2005). The current study employed a 
perinatal dosing timeline, but contact with this endocrine disruptor does not abruptly end 
just prior to adolescence. Although this exposure paradigm was chosen to capture 
specific developmental effects of BPA, future research should also examine the effects of 
exposure that continues throughout adolescence and adulthood including exposure during 
the time of behavioral testing, as well as exposure that happens only during adulthood. 
These exposure paradigms are necessary to examine what effects long-term exposure to 
BPA may be having on anxiogenic behaviors as well as provide important perspective in 
interpreting how exposure during early development may produce effects that are unique 
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from exposure that occurs later in the lifespan. Because of BPA’s extremely short half-
life (Doerge, Twaddle, Woodling, & Fisher, 2010), it would be necessary to accurately 
control the time frame between dosing and testing to ensure a consistent body burden 
across animals.  
 In addition, the current experiment examined the effects of developmental 
exposure on “baseline” behavior only. The subjects were perinatally treated with BPA, 
allowed to mature, and then tested once on either the anxiety or depression tasks when 
they reached adulthood. In reality, people are not exposed only to BPA; they are exposed 
to various other toxins, drugs, and stressful situations, all of which may act in concert 
with BPA-induced alterations in the brain to affect behavior. To reiterate, BPA has been 
shown to modify both dopaminergic and estrogenic function (Bouskine et al., 2009; 
Ramos et al., 2003; Tian et al., 2010; Zsarnovszky et al., 2005). However, in order to 
recognize these modifications, future research may need to incorporate some type of 
pharmacological or behavioral challenge (such as a drug challenge or stress) prior to 
behavioral testing for anxiety and depression. In other words, the subtle effects of BPA 
may not be obvious without some type of “pretreatment” that will strain the system and 
make BPA-induced alterations easier to detect. Given the subtle results observed in this 
study, one obvious study would be to administer a known anxiogenic drug or anti-
depressant in controls and BPA exposed animals just prior to behavioral testing.  
Limitations 
One limitation to this study was the use of EE2 as a positive control. It should be 
noted that there is still much controversy among those doing research with BPA about the 
usefulness of having a positive control in an experiment examining behavior in whole 
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animals (Ryan, Hotchkiss, Crofton, & Gray, 2010). Based on recommendations from the 
National Toxicology Program for those doing research on BPA, we chose to include the 5 
μg/kg/day dose of EE2 (National Toxicology Program [NTP], 2001). However, in whole 
animals the positive control substance can affect numerous other body systems other than 
the one of primary interest, and these secondary effects could interfere with the 
interpretation of behavioral results (Ryan et al., 2010). In this study, numerous males in 
the positive control group became quite sick during adulthood and were unable to be 
tested. Upon autopsy on a few of these sick mice, it was determined that their 
reproductive systems showed sepsis. EE2 is a synthetic hormone and was apparently able 
to extensively affect some of their reproductive organs. Thus, there is considerable 
question about whether EE2 served its purpose as a true positive control. 
This was one of only a few studies in whole animals using EE2, and it is 
retrospectively acknowledged that it may not have been the best choice for a positive 
control substance. Other studies examining the behavioral effects of exposure to BPA 
have used the pesticide methoxyclor as the positive control (Gioiosa et al., 2007; Palanza 
et al. 2008; Panzica et al. 2007). Like BPA, methoxyclor is also estrogenic and may be 
better tolerated. The utility of using it as a positive control in whole animals, however, is 
still unresolved (vom Saal et al., 2010).  
Conclusions 
 BPA is a ubiquitous estrogenic endocrine disruptor that has been shown to elicit 
harmful effects in a range of target tissues, especially neurological and reproductive. The 
current study’s results indicate that developmental exposure to BPA could be affecting 
anxiety behaviors during adulthood. Future research will be necessary to 
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Dependent Variables Analyzed 
________________________________________________________________________ 
Behavior 
__Test Paradigm   Dependent Variables_________________________ 
Anxiety 
OFT     HORIZONTAL MEASURES: 
a) Number of photobeam breaks in the center area* 
b) Number of photobeam breaks in the periphery* 
c) Duration of time spent in the center area* 
d) Duration of time spent frozen in the center area* 
e) Duration of time spent frozen in the periphery * 
VERTICAL MEASURES: 
f) Number of vertical photobeam breaks in the   
center area  
g) Number of vertical photobeam breaks in the 
periphery 
h) Duration of time spent vertical in the center area 
i) Duration of time spent vertical in the periphery  
 
EPM    a) Number of total closed arm entries (all paws into 
   arm) 
b) Number of total open arm entries (all paws into 
arm) 
c) Percent open entries 
d) Percent time spent in closed arms 
e) Percent time spent in open arms 
f) Percent time spent in junction of maze 
g) Duration spent grooming  
h) Frequency of rearing 
i) Frequency of head dipping (head/shoulders over 
the side of the maze) 
j) Frequency of stretched-attend postures (body 
stretched forward then retracted) 
Depression 
    TST     a) Duration of immobility*  
     
    FST     a) Average immobility* 
     b) Latency to immobility 
     c) Basic movements  
     d) Swim distance     
* Analyzed minute by minute
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Table 2  
 
Summary of the Effects of Developmental EE2 and BPA Exposure on Measures of Anxiety Relative to Non-exposed Controls 
                        Behavioral Test  
Exposure Group                                      OFT                                                                 EPM       
 
2 µg/kg/day BPA                 overall ↓ vertical time in center                = control        
 




20 µg/kg/day BPA                       overall ↑ time frozen in center (females only)             overall ↑ time spent in junction  
 
200 µg/kg/day BPA                 overall ↓ vertical time in center      = control 
 




          males >> females: vertical photobeam breaks in center 
  
5 µg/kg/day EE2            overall ↓ vertical time in center       = control 
 
         overall ↑ time frozen in periphery (males only)      
             
         overall ↓ vertical photobeam breaks in center (males only) 
 







     
         males > females (vertical photobeam breaks in periphery)                  
 
Notes. OFT = Open Field Test, EPM = Elevated Plus Maze, BPA = Bisphenol A, EE2 = Ethinyl Estradiol, ↓ decreased, ↑ increased,  
= equal to, > greater than, >>much greater than  
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Table 3  
 
Summary of the Effects of Developmental EE2 and BPA Exposure on Measures of Depression Relative to Non-exposed Controls 
                       Behavioral Test  
 
Exposure Group                            TST                                                                 FST       
 
2 µg/kg/day BPA                 = control                        = control             
                             
20 µg/kg/day BPA                  = control                       ↓ immobility relative  
                                                                            to controls (1
st
 min only) 
                      
200 µg/kg/day BPA                       = control                       ↓ immobility relative 
                                                                                                 to controls (1
st
 min only) 
 
5 µg/kg/day EE2                     = control                       ↓ immobility relative 
                              to controls (1
st
 min only) 
 
Notes. TST = Tail Suspension Test, FST = Forced Swim Test, BPA = Bisphenol A, EE2 = Ethinyl Estradiol, ↓ decreased, ↑ increased,  











                      
 
 















 Figure 2. Open Field Test:  Average time spent per minute in the center of the chamber. BPA = Bisphenol A; EE2 = 





Figure 3. Open Field Test:  Average time per minute spent frozen in the center of the chamber. BPA = Bisphenol A; EE2 = 




Figure 4. Open Field Test:  Average time per minute spent frozen in the periphery of the chamber. BPA = Bisphenol A; EE2 





Figure 5. Open Field Test:  Number of vertical counts in the center of the chamber. BPA = Bisphenol A; EE2 = Ethinyl 
Estradiol; SEM = Standard Error of the Mean; 
#
p = .001 between males and females; 
+





Figure 6. Open Field Test:  Vertical counts in the periphery. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = Standard 
Error of the Mean; 
#





Figure 7. Open Field Test:  Time spent vertical in the center of the chamber. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; 
SEM = Standard Error of the Mean; *p < .05 from controls; 
+
p = .078 from controls 
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 Figure 8. Elevated Plus Maze:  Number of entries into closed arms. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = 
Standard Error of the Mean 
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 Figure 9. Elevated Plus Maze:  Percent of open arm entries. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = 





Figure 10. Elevated Plus Maze:  Percent time spent in the closed arms. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; 





Figure 11. Elevated Plus Maze:  Percent time spent in the junction. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = 





Figure 12. Elevated Plus Maze:  Number of stretch-attend postures. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = 
Standard Error of the Mean 
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 Figure 13. Forced Swim Test:  Average time immobile per minute. BPA = Bisphenol A; EE2 = Ethinyl Estradiol; SEM = 
Standard Error of the Mean; *p < .05 from control group 
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